Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

被引：0
|
作者：
Z. Wang
Z. Zhao
Y. Xia
Z. Cai
C. Wang
Y. Shen
R. Liu
H. Qin
J. Jia
G. Yuan
机构：
[1] Affiliated Hospital of Jiangsu University,Department of Endocrinology
来源：
Journal of Endocrinological Investigation | 2022年 / 45卷
关键词：
WGCNA; Single-cell RNA-seq; NASH; Fibrosis; HCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1379 / 1392
页数：13
相关论文
共 50 条
  • [1] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [2] Systematic review of fibrosis progression in nonalcoholic steatohepatitis (NASH)
    Argo, Curtis K.
    Northup, Patrick G.
    Caldwell, Stephen H.
    HEPATOLOGY, 2006, 44 (04) : 650A - 651A
  • [3] Predictors of fibrosis in nonalcoholic steatohepatitis (NASH)
    Copaci, I
    Micu, L
    Cojocaru, L
    Voiculescu, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 192 - 192
  • [4] Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
    Qi, Xiaoyan
    Lai, Jinping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [5] IDENTIFICATION OF SERUM METABOLITES AS DIAGNOSTIC BIOMARKERS FOR ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Lawitz, Eric J.
    Alkhouri, Naim
    Wong, Vincent Wai-Sun
    Romero-Gomez, Manuel
    Okanoue, Takeshi
    Trauner, Michael H.
    Chuang, Jay
    Billin, Andrew
    Wang, Ya
    Chen, Guang
    Myers, Robert P.
    Djedjos, Stephen
    Goodman, Zackary
    Harrison, Stephen A.
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 1042A - 1042A
  • [6] Predicting nonalcoholic steatohepatitis (NASH) using mechanistic biomarkers
    Tan, Eunice
    Jumat, Nur Halisa
    Soon, Gwyneth Shook Ting
    Lee, Jonathan Wei Jie
    Dan, Yock Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 425 - 425
  • [7] BIOMARKERS AND CLINICAL CHARACTERISTICS ASSOCIATED WITH NONALCOHOLIC STEATOHEPATITIS FIBROSIS PROGRESSION: CENTAUR STUDY
    Lanthier, Nicolas
    Kluwe, Johannes
    Fowell, Andrew J.
    Jablkowski, Maciej
    Wong, Vincent
    Yuan, Jiacheng
    Muthian, Sean
    Nicandro, Jean Paul A.
    Seyedkazemi, Star
    Martins, Eduardo B.
    Fischer, Laurent
    Loomba, Rohit
    GASTROENTEROLOGY, 2019, 156 (06) : S1235 - S1235
  • [8] Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH).
    Costanzo, M
    Miele, L
    Di Rocco, P
    Forgione, A
    Alfei, B
    Pompili, M
    Rapaccini, GL
    Grieco, A
    Gasbarrini, G
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [9] COMPLEX ROLE OF OSTEOPONTIN IN THE PROGRESSION OF NONALCOHOLIC STEATOHEPATITIS (NASH)
    Jindal, A.
    Sutti, S.
    Locatelli, I.
    Chiocchetti, A.
    Soluri, M. F. F.
    Vacchiano, M.
    Maldi, E.
    Bozzola, C.
    Dianzani, U.
    Albano, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S512 - S512
  • [10] Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
    Wattacheril, Julia
    Issa, Danny
    Sanyal, Arun
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 649 - 662
12345